NL192870B - Anti-hypertensief oraal farmaceutisch preparaat. - Google Patents

Anti-hypertensief oraal farmaceutisch preparaat.

Info

Publication number
NL192870B
NL192870B NL7812164A NL7812164A NL192870B NL 192870 B NL192870 B NL 192870B NL 7812164 A NL7812164 A NL 7812164A NL 7812164 A NL7812164 A NL 7812164A NL 192870 B NL192870 B NL 192870B
Authority
NL
Netherlands
Prior art keywords
pharmaceutical preparation
oral pharmaceutical
hypertensive
hypertensive oral
preparation
Prior art date
Application number
NL7812164A
Other languages
English (en)
Other versions
NL7812164A (nl
NL192870C (nl
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25343256&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL192870(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of NL7812164A publication Critical patent/NL7812164A/nl
Publication of NL192870B publication Critical patent/NL192870B/nl
Application granted granted Critical
Publication of NL192870C publication Critical patent/NL192870C/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NL7812164A 1977-12-27 1978-12-14 Anti-hypertensief oraal farmaceutisch preparaat. NL192870C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86442877A 1977-12-27 1977-12-27
US86442877 1977-12-27

Publications (3)

Publication Number Publication Date
NL7812164A NL7812164A (nl) 1979-06-29
NL192870B true NL192870B (nl) 1997-12-01
NL192870C NL192870C (nl) 1998-04-02

Family

ID=25343256

Family Applications (2)

Application Number Title Priority Date Filing Date
NL7812164A NL192870C (nl) 1977-12-27 1978-12-14 Anti-hypertensief oraal farmaceutisch preparaat.
NL980017C NL980017I1 (nl) 1977-12-27 1998-04-24 Anti-hypertensief oraal farmaceutisch preparaat.

Family Applications After (1)

Application Number Title Priority Date Filing Date
NL980017C NL980017I1 (nl) 1977-12-27 1998-04-24 Anti-hypertensief oraal farmaceutisch preparaat.

Country Status (30)

Country Link
JP (1) JPS54110333A (nl)
AR (1) AR230378A1 (nl)
AU (1) AU526239B2 (nl)
BE (1) BE873092A (nl)
CA (1) CA1120400A (nl)
CH (1) CH642542A5 (nl)
DE (1) DE2854316C3 (nl)
DK (1) DK578778A (nl)
EG (1) EG14178A (nl)
FI (1) FI783991A (nl)
FR (1) FR2413089A1 (nl)
GB (1) GB2010675B (nl)
GR (1) GR72951B (nl)
HK (1) HK45483A (nl)
HU (1) HU178747B (nl)
IE (1) IE48306B1 (nl)
IL (1) IL56281A (nl)
IT (1) IT1202811B (nl)
KE (1) KE3235A (nl)
LU (1) LU80709A1 (nl)
MY (2) MY8300240A (nl)
NL (2) NL192870C (nl)
NO (1) NO784357L (nl)
NZ (1) NZ189159A (nl)
PH (1) PH22111A (nl)
PL (1) PL212188A1 (nl)
PT (1) PT68983A (nl)
SE (1) SE445173B (nl)
SG (1) SG41482G (nl)
ZA (1) ZA786948B (nl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5829950B2 (ja) * 1978-10-05 1983-06-25 ウェルファイド株式会社 環状イミノカルボン酸誘導体およびその塩類
US4350704A (en) 1980-10-06 1982-09-21 Warner-Lambert Company Substituted acyl derivatives of octahydro-1H-indole-2-carboxylic acids
US4482725A (en) * 1980-04-03 1984-11-13 E. R. Squibb & Sons, Inc. S-Acylation products of mercaptoacyl amino acids and carboxyl group containing diuretics
US4344949A (en) 1980-10-03 1982-08-17 Warner-Lambert Company Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
US4532342A (en) * 1981-02-20 1985-07-30 Warner-Lambert Company N-substituted amino acids as intermediates in the preparation of acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
US4552889A (en) * 1983-06-09 1985-11-12 Eli Lilly And Company 3-Mercaptomethyl-2-oxo-1-pyrrolidine acetic acids and use for hypertension
US4898729A (en) * 1983-12-09 1990-02-06 Euroceltique, S.A. Treatment of hypertension, compounds and compositions for antihypertension and diuresis
DE3532036A1 (de) * 1985-09-09 1987-03-26 Hoechst Ag Pharmazeutische zubereitung zur behandlung des bluthochdrucks
DK9200258U4 (da) * 1992-03-11 1993-07-23 Merck & Co Inc Farmaceutisk præparat indeholdende enalapril til brug mod hypertension
WO1996024358A1 (en) * 1995-02-10 1996-08-15 G.D. Searle & Co. Use of low dose amount of spironolactone for treatment of cardiovascular disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU509899B2 (en) * 1976-02-13 1980-05-29 E.R. Squibb & Sons, Inc. Proline derivatives and related compounds

Also Published As

Publication number Publication date
PH22111A (en) 1988-06-01
NZ189159A (en) 1984-12-14
AU526239B2 (en) 1982-12-23
IE782413L (en) 1979-06-27
PT68983A (en) 1979-01-01
LU80709A1 (de) 1979-04-13
IT7831266A0 (it) 1978-12-22
MY8300240A (en) 1983-12-31
CA1120400A (en) 1982-03-23
IL56281A0 (en) 1979-03-12
JPS54110333A (en) 1979-08-29
KE3235A (en) 1982-11-05
CH642542A5 (de) 1984-04-30
DK578778A (da) 1979-06-28
EG14178A (en) 1984-06-30
GB2010675A (en) 1979-07-04
NL980017I1 (nl) 1998-07-01
JPS647045B2 (nl) 1989-02-07
HK45483A (en) 1983-10-28
IE48306B1 (en) 1984-12-12
SE445173B (sv) 1986-06-09
SE7813277L (sv) 1979-06-28
ZA786948B (en) 1980-04-30
NL7812164A (nl) 1979-06-29
FR2413089A1 (fr) 1979-07-27
MY102991A (en) 1993-03-31
IL56281A (en) 1983-05-15
SG41482G (en) 1985-01-11
GR72951B (nl) 1984-01-17
AR230378A1 (es) 1984-04-30
DE2854316C2 (nl) 1989-08-10
DE2854316C3 (de) 1994-12-22
BE873092A (fr) 1979-06-27
IT1202811B (it) 1989-02-09
AU4204178A (en) 1979-07-05
PL212188A1 (nl) 1980-02-11
HU178747B (en) 1982-06-28
DE2854316A1 (de) 1979-07-05
FR2413089B1 (nl) 1980-12-26
FI783991A (fi) 1979-06-28
NO784357L (no) 1979-06-28
GB2010675B (en) 1982-06-16
NL192870C (nl) 1998-04-02

Similar Documents

Publication Publication Date Title
NL7801187A (nl) Farmaceutisch tablet.
SE7810591L (sv) Farmaceutiska kompositioner
SE7803527L (sv) Lekemedelsdosenhet
FI800910A (fi) Farmaceutiskt anvaendbara 4-amino-3-kinolinkarboxylsyror och -estrar
NO153795C (no) Munnpleiemiddel.
SE7709359L (sv) Farmaceutisk doseringsform
SE418053B (sv) Oral beredning
BE871584A (fr) Preparations pharmaceutiques
NL7805476A (nl) Gebitsconstructie.
SE7711395L (sv) Farmaceutisk komposition
DK152333C (da) Indretning til oral indgivelse til droevtyggere
BE864359A (fr) Compositions pharmaceutiques antioestrogenes
SE7809373L (sv) Farmaceutiskt anvendbara 5-hydroxi-1h-imidazol-4-karboxamidderivat
NL7711446A (nl) Pharmaceutische desinfecterend preparaat.
IT7821686A0 (it) Composizione farmaceutica.
NO147437C (no) Partikkelformig forstoff for droevtyggere.
NL980017I1 (nl) Anti-hypertensief oraal farmaceutisch preparaat.
FI783223A (fi) Pyrazinobensoxatsepinderivat, foerfaranden foer deras framstaellning och desamma innehaollande farmaceutiska blandningar
NL7801921A (nl) Farmaceutische preparaten.
IT7849938A0 (it) Composizioni farmaceutiche
NL7809626A (nl) Therapeutische preparaat.
SE7806441L (sv) Lekemedelskomposition
NL7804887A (nl) Bisamidine-verbindingen, hun bereiding, en farmaceuti- sche mengsels die hen bevatten.
FI773812A (fi) Farmaceutiska foereningar
NL7800191A (nl) Anthelmintisch preparaat.

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
AC1 Application for a supplementary protection certificate

Free format text: 980017, 980424

BC1 Further communications concerning applications for a supplementary protection certificate

Free format text: 980017

BC1 Further communications concerning applications for a supplementary protection certificate

Free format text: 980017

V4 Discontinued because of reaching the maximum lifetime of a patent

Free format text: 981214